BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34924263)

  • 1. Lung transplant recipients with idiopathic pulmonary fibrosis have impaired alloreactive immune responses.
    Wang P; Leung J; Lam A; Lee S; Calabrese DR; Hays SR; Golden JA; Kukreja J; Singer JP; Wolters PJ; Tang Q; Greenland JR
    J Heart Lung Transplant; 2022 May; 41(5):641-653. PubMed ID: 34924263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired Cytomegalovirus Immunity in Idiopathic Pulmonary Fibrosis Lung Transplant Recipients with Short Telomeres.
    Popescu I; Mannem H; Winters SA; Hoji A; Silveira F; McNally E; Pipeling MR; Lendermon EA; Morrell MR; Pilewski JM; Hanumanthu VS; Zhang Y; Gulati S; Shah PD; Iasella CJ; Ensor CR; Armanios M; McDyer JF
    Am J Respir Crit Care Med; 2019 Feb; 199(3):362-376. PubMed ID: 30088779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of age and telomere length on circulating T cells and rejection risk after lung transplantation for idiopathic pulmonary fibrosis.
    Snyder ME; Anderson MR; Benvenuto LJ; Sutton RM; Bondonese A; Koshy R; Burke R; Clifford S; Craig A; Iasella CJ; Hannan SJ; Popescu I; Zhang Y; Sanchez PG; Alder JK; McDyer JF
    J Heart Lung Transplant; 2023 Dec; 42(12):1666-1677. PubMed ID: 37544465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung transplantation for idiopathic pulmonary fibrosis enriches for individuals with telomere-mediated disease.
    Alder JK; Sutton RM; Iasella CJ; Nouraie M; Koshy R; Hannan SJ; Chan EG; Chen X; Zhang Y; Brown M; Popescu I; Veatch M; Saul M; Berndt A; Methé BA; Morris A; Pilewski JM; Sanchez PG; Morrell MR; Shapiro SD; Lindell KO; Gibson KF; Kass DJ; McDyer JF
    J Heart Lung Transplant; 2022 May; 41(5):654-663. PubMed ID: 34933798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung transplant recipients with telomere-mediated pulmonary fibrosis have increased risk for hematologic complications.
    Hannan SJ; Iasella CJ; Sutton RM; Popescu ID; Koshy R; Burke R; Chen X; Zhang Y; Pilewski JM; Hage CA; Sanchez PG; Im A; Farah R; Alder JK; McDyer JF
    Am J Transplant; 2023 Oct; 23(10):1590-1602. PubMed ID: 37392813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of single vs bilateral lung transplantation on plasma surfactant protein D levels in idiopathic pulmonary fibrosis.
    Sims MW; Beers MF; Ahya VN; Kawut SM; Sims KD; Lederer DJ; Palmer SM; Wille K; Lama VN; Shah PD; Orens JB; Bhorade S; Crespo M; Weinacker A; Demissie E; Bellamy S; Christie JD; Ware LB;
    Chest; 2011 Aug; 140(2):489-496. PubMed ID: 21349925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomeres in Interstitial Lung Disease: The Short and the Long of It.
    Courtwright AM; El-Chemaly S
    Ann Am Thorac Soc; 2019 Feb; 16(2):175-181. PubMed ID: 30540921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Expressed Macrophage Scavenger Receptor 1 Predicts Severity Clinical Outcome in Transplant Patient in Idiopathic Pulmonary Fibrosis Disease.
    Zheng M; Tian T; Liang J; Ye S; Chen J; Ji Y
    J Immunol Res; 2021; 2021():6690100. PubMed ID: 33604393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary Fibrosis.
    Newton CA; Zhang D; Oldham JM; Kozlitina J; Ma SF; Martinez FJ; Raghu G; Noth I; Garcia CK
    Am J Respir Crit Care Med; 2019 Aug; 200(3):336-347. PubMed ID: 30566847
    [No Abstract]   [Full Text] [Related]  

  • 10. From organ to cell: Multi-level telomere length assessment in patients with idiopathic pulmonary fibrosis.
    van Batenburg AA; Kazemier KM; van Oosterhout MFM; van der Vis JJ; van Es HW; Grutters JC; Goldschmeding R; van Moorsel CHM
    PLoS One; 2020; 15(1):e0226785. PubMed ID: 31910222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of immunologic status of liver transplant recipients by peripheral blood mononuclear cells in response to stimulation by donor alloantigen.
    Chen Y; McKenna GJ; Yoshida EM; Buczkowski AK; Scudamore CH; Erb SR; Steinbrecher UP; Chung SW
    Ann Surg; 1999 Aug; 230(2):242-50. PubMed ID: 10450739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomere length across different UIP fibrotic-Interstitial Lung Diseases: a prospective Greek case-control study.
    Tomos I; Karakatsani A; Manali ED; Kottaridi C; Spathis A; Argentos S; Papiris SA
    Pulmonology; 2022; 28(4):254-261. PubMed ID: 33358512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of gastroesophageal reflux disease on idiopathic pulmonary fibrosis and lung transplant recipients.
    Reddy CA; Wakwaya YT
    Curr Opin Gastroenterol; 2022 Jul; 38(4):411-416. PubMed ID: 35762701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of suppressor of cytokine signaling 1 in the peripheral blood of patients with idiopathic pulmonary fibrosis.
    Bao Z; Zhang Q; Wan H; He P; Zhou X; Zhou M
    Chin Med J (Engl); 2014; 127(11):2117-20. PubMed ID: 24890164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing study.
    Dressen A; Abbas AR; Cabanski C; Reeder J; Ramalingam TR; Neighbors M; Bhangale TR; Brauer MJ; Hunkapiller J; Reeder J; Mukhyala K; Cuenco K; Tom J; Cowgill A; Vogel J; Forrest WF; Collard HR; Wolters PJ; Kropski JA; Lancaster LH; Blackwell TS; Arron JR; Yaspan BL
    Lancet Respir Med; 2018 Aug; 6(8):603-614. PubMed ID: 29891356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated plasma long pentraxin-3 levels and primary graft dysfunction after lung transplantation for idiopathic pulmonary fibrosis.
    Diamond JM; Lederer DJ; Kawut SM; Lee J; Ahya VN; Bellamy S; Palmer SM; Lama VN; Bhorade S; Crespo M; Demissie E; Sonett J; Wille K; Orens J; Shah PD; Weinacker A; Weill D; Kohl BA; Deutschman CC; Arcasoy S; Shah AS; Belperio JA; Wilkes D; Reynolds JM; Ware LB; Christie JD;
    Am J Transplant; 2011 Nov; 11(11):2517-22. PubMed ID: 21883907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral blood myeloid-derived suppressor cells reflect disease status in idiopathic pulmonary fibrosis.
    Fernandez IE; Greiffo FR; Frankenberger M; Bandres J; Heinzelmann K; Neurohr C; Hatz R; Hartl D; Behr J; Eickelberg O
    Eur Respir J; 2016 Oct; 48(4):1171-1183. PubMed ID: 27587556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation.
    Stuart BD; Lee JS; Kozlitina J; Noth I; Devine MS; Glazer CS; Torres F; Kaza V; Girod CE; Jones KD; Elicker BM; Ma SF; Vij R; Collard HR; Wolters PJ; Garcia CK
    Lancet Respir Med; 2014 Jul; 2(7):557-65. PubMed ID: 24948432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between telomere length and survival in patients with idiopathic pulmonary fibrosis.
    Dai J; Cai H; Li H; Zhuang Y; Min H; Wen Y; Yang J; Gao Q; Shi Y; Yi L
    Respirology; 2015 Aug; 20(6):947-52. PubMed ID: 26073170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single Versus Bilateral Lung Transplantation for Idiopathic Pulmonary Fibrosis in the Lung Allocation Score Era.
    Spratt JR; Tomic R; Brown RZ; Rudser K; Loor G; Hertz M; Shumway S; Kelly RF
    J Surg Res; 2019 Feb; 234():84-95. PubMed ID: 30527505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.